Delivery Order SPE2DB20D3103-SPE2DB25FL9L5
Award Date
12/10/24
Potential Completion Date
12/11/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,258.90, is for the delivery of ondansetron hydrochloride 8 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, SPE2DB20D3103|SPE2DB25FL9X1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,762.74 firm fixed-price delivery order is for the supply of 4566705223 - Ondansetron HCL 8 mg Tablets, 30s, with a completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,044.84, for the supply of Ondansetron HCL 8 mg Tablets. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.94 firm fixed-price delivery order is for the supply of 4565897005 - Ondansetron HCL 8 mg Tablets, 500 count. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.49 Firm Fixed Price Delivery Order contract is for the supply of 4562462575 - Ondansetron HCL 8 mg Tablet 30s, and has an ultimate completion date of October 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAER4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,953.63, is a Delivery Order for the supply of Ondansetron ODT 8 mg Tablets in 30-count packages. This contract is not designated as a set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award, with ID SPE2DB22D1202|SPE2DB25FUHX7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,356.98, is for the delivery of Ondansetron ODT 4 MG tablets and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,543.18 fixed-price contract is for the delivery of 500 units of Ondansetron HCL 8 mg tablets. The contract has no set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $6,306.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 8 mg tablets in 30-count packages. It is a firm-fixed-price delivery order with a completion date of January 8, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, SPE2DB22D3301|SPE2DB25FY0ZR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,049.97, is for the delivery of Ondansetron ODT 4 mg tablets. It is a firm-fixed-price delivery order contract with a period of performance extending to March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...